Correlation Between Spyre Therapeutics and ALTRIA

Can any of the company-specific risk be diversified away by investing in both Spyre Therapeutics and ALTRIA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spyre Therapeutics and ALTRIA into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Spyre Therapeutics and ALTRIA GROUP INC, you can compare the effects of market volatilities on Spyre Therapeutics and ALTRIA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spyre Therapeutics with a short position of ALTRIA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spyre Therapeutics and ALTRIA.

Diversification Opportunities for Spyre Therapeutics and ALTRIA

0.36

Correlation Coefficient

Spyre Therapeutics  ALTRIA

Weak diversification

The 3 months correlation between Spyre and ALTRIA is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Spyre Therapeutics and ALTRIA GROUP INC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ALTRIA GROUP INC and Spyre Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spyre Therapeutics are associated (or correlated) with ALTRIA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ALTRIA GROUP INC has no effect on the direction of Spyre Therapeutics i.e., Spyre Therapeutics and ALTRIA go up and down completely randomly.

Pair Corralation between Spyre Therapeutics and ALTRIA

Given the investment horizon of 90 days Spyre Therapeutics is expected to under-perform the ALTRIA. In addition to that, Spyre Therapeutics is 6.36 times more volatile than ALTRIA GROUP INC. It trades about -0.03 of its total potential returns per unit of risk. ALTRIA GROUP INC is currently generating about -0.12 per unit of volatility. If you would invest  9,858  in ALTRIA GROUP INC on October 10, 2024 and sell it today you would lose (429.00) from holding ALTRIA GROUP INC or give up 4.35% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	98.36%
Values	Daily Returns

Spyre Therapeutics  vs.  ALTRIA GROUP INC

Spyre Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Spyre Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

ALTRIA GROUP INC

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days ALTRIA GROUP INC has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, ALTRIA is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Spyre Therapeutics and ALTRIA

The main advantage of trading using opposite Spyre Therapeutics and ALTRIA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spyre Therapeutics position performs unexpectedly, ALTRIA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ALTRIA will offset losses from the drop in ALTRIA's long position.

The idea behind Spyre Therapeutics and ALTRIA GROUP INC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.